- Home
- AARD vs AHMA Comparison
AARD vs AHMA Comparison
Compare AARD & AHMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | AHMA |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United Arab Emirates |
| Employees | 40 | 44 |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 74.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AARD | AHMA |
|---|---|---|
| Price | $4.87 | $1.94 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | 123.0K | ★ 5.8M |
| Earning Date | 05-14-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $180.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $0.76 |
| 52 Week High | $17.94 | $39.50 |
Technical Indicators
Market Signals| Indicator | AARD | AHMA |
|---|---|---|
| Relative Strength Index (RSI) | 61.92 | 56.42 |
| Support Level | $4.81 | $0.96 |
| Resistance Level | $5.83 | $5.40 |
| Average True Range (ATR) | 0.34 | 0.67 |
| MACD | 0.15 | 0.07 |
| Stochastic Oscillator | 83.43 | 20.43 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.